Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with Prognosis

29 Sept 2020

Abstract excerpt

Non-muscle invasive bladder cancer (NMIBC), which is characterized by a recurrence rate of approximately 30% and very long treatment times, remains a major unresolved problem for patients and the health care system. The immunological interplay between tumor cells and the immune environment is important for tumor development. Therefore, we analyzed the mRNA of three immune markers, CXCL9, PD1 and PD-L1, in NMIBC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer Immunotherapy and Biomarkers
Share to Urinary and Genital Oncology Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33003392
DOI: 10.3390/cancers12102794

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of CXCL9, PD1 and PD-L1 mRNA in Stage T1 Non-Muscle Invasive Bladder Cancer and Their Association with PrognosisPMID 33003392Read ↗

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancerSemantic proximity Read ↗

MMP9 is a prognostic marker for bladder cancer and relates to the Immune Cell Infiltration in the Tumor MicroenvironmentSemantic proximity Read ↗

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancerSemantic proximity Read ↗

Knockdown of CSF1R molecules enhances the anti-tumor effects of CD8 + T lymphocytes in bladder cancerSemantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

Unveiling clinical significance and tumor immune landscape of CXCL12 in bladder cancer: Insights from multiple omics analysisSemantic proximity Read ↗

PD-L1 expression and its correlation with tumor biomarkers in Chinese urothelial bladder cancer.Semantic proximity Read ↗

Sexual Dimorphism in Outcomes of Non–muscle-invasive Bladder Cancer: A Role of CD163+ Macrophages, B cells, and PD-L1 Immune CheckpointSemantic proximity Read ↗

Sexual dimorphism in outcomes of non-muscle invasive bladder cancer: a role of CD163+ M2 macrophages, B cells and PD-L1 immune checkpointSemantic proximity Read ↗

Comprehensive Landscape of Non-muscle Invasive Bladder Cancer Tumour Microenvironment and Prognostic value of Cancer-Associated MyofibroblastsSemantic proximity Read ↗

CXCL12, A Potential Biomarker and A Vital Modulator of Tumor Immune Microenvironment (TIME) of Bladder Cancer: From A Comprehensive Analysis of TCGA DatabaseSemantic proximity Read ↗

Exploration of Prognostic Biomarkers and Therapeutic Targets in The Microenvironment of Bladder Cancer Based on CXC ChemokinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.